Opioids/cannabinoids as a potentialtherapeutic approach in COVID-19 patients.
Opioids and cannabinoids are a group of endogenous and exogenous compounds that function through activation of their respective receptors (opioid...
Combined vapor exposure to THC and alcohol in pregnant rats: Maternal outcomes and pharmacokinetic effects
Aug 10, 2022
Cannabis is the most frequently used illicit drug among pregnant women, yet the potential consequences of prenatal cannabis exposure on...
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
Aug 10, 2022
Background: Current arthritis treatments often have side-effects attributable to active compounds as well as route of administration. Cannabidiol (CBD) attenuates...
Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals
Aug 10, 2022
Endocannabinoids have analgesic/anti-inflammatory properties. The biology of endocannabinoids, their receptors, signalling mechanisms and role in the regulation of physiological processes...
Cannabidiol, a major non-psychotropic cannabis constituent enhances fracture healing and stimulates hydroxylase activity in osteoblasts
Aug 10, 2022
Cannabinoid ligands regulate bone mass, but skeletal effects of cannabis (marijuana and hashish) have not been reported. Bone fractures are...
Delta-9-tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARy and CB1 receptors
Aug 10, 2022
Background and Purpose Δ9-Tetrahydrocannabinolic acid (Δ9-THCA-A), the precursor of Δ9-THC, is a non-psychotropic phytocannabinoid that shows PPARγ agonist activity. Here,...
Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis
Aug 10, 2022
The aim of this study was to evaluate the efficacy of oral transmucosal (OTM) cannabidiol (CBD), in addition to a...
Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs
Aug 10, 2022
The objective of this study was to provide preliminary data describing the safety and effect of cannabidiol (CBD) for symptom...
Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs.
Aug 10, 2022
Objective—To determine the effects of topically applied 2% delta-9-tetrahydrocannabinol (THC) ophthalmic solution on aqueous humor flow rate (AHFR) and intraocular...
Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in Human and Canine Glioma Cells
Aug 10, 2022
Cannabidiol (CBD), the major non-psychoactive compound found in cannabis, is frequently used both as a nutraceutical and therapeutic. Despite anecdotal...
Search Our Website
Recent In The News
- CBD Oracle Interviews VCS Board and Sponsors
- New York Times: Mammals with the Munchies
- Check out this article highlighting VCS in the newest issue of “Cannabis and Tech Today.
- BREAKING NEWS! Check out this recently released statement from the U.S. Food and Drug Administration about next steps to explore potential regulatory pathways for CBD products!
- Cannabis in Veterinary Medicine | Continual Education | VIN
- Check out this conversation with VCS Founders Dr. Gary Richter, Dr. Trina Hazzah, and Charles Lozow on the importance of advocating for the safe use of cannabis in pets
- A Dose Finding Study of Cannabidiol in Dogs with Intractable Epilepsy
- Earth Buddy, Pet Calming Study – Press Release
- CALIFORNIA CANNABIS UPDATES – April 2022
- Cannabis in Veterinary Practice Multi-Expert Webinar